The healthcare industry — from providers and health systems to payers — is increasingly adopting value-based care practices, which is not surprising given that approximately 61% of all healthcare payments are tied to value and quality in some way. In… Continue Reading
Multiple sclerosis (MS) is a chronic illness in which the body’s immune system attacks myelin, the substance that surrounds and protects the nerve fibers of the central nervous system. The result is a disabling disease that causes damage to… Continue Reading
Delivering Real World Data-Driven Insights:An Executive Interview with Wendy Shusko and Jason Drenning Wendy Shusko, President and CEO and Jason Drenning, PhD, Chief Commercial Officer of STATinMED Research sat down with HealthEconomics.Com to discuss the data landscape, industry trends and… Continue Reading
As biopharma makes the shift toward a personalized healthcare system, it is also transitioning towards a pipeline full of innovative, high-cost therapies. We are moving to a value-based system, with two of the biggest ideas for this decade becoming more… Continue Reading
Shelby CormanPharmerit International Real-world evidence is a key component of value demonstration for pharmaceuticals, diagnostic agents, and medical devices throughout the product lifecycle. Planning for real-world evidence needs early in the pre-launch period can allow for seamless integration of health… Continue Reading
